Women age 18-45
Within 6 months of expiration or beyond the end of the FDA-approved duration of use of the levonorgestrel intrauterine device (LNG-IUD = 5 years) OR the etonogestrel-releasing subdermal implant (ENG implant = 3 years)
Able to consent in English or Spanish.
Not pregnant at the time of enrollment

NCT02267616_inc_T1
Person
Women
NCT02267616_inc_T2
Person
age
NCT02267616_inc_T3
Value
18-45
NCT02267616_inc_T6
Negation
Not
NCT02267616_inc_T7
Condition
pregnant
NCT02267616_inc_T8
Temporal
at the time of enrollment